NYSEAMERICAN:PLX - Protalix BioTherapeutics, Inc.
$0.39
 $-0.01
-2.69%
4:00PM EDT
2019-05-24
Protalix BioTherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system, ProCellEx. Using its ProCellEx system, the Company is developing a pipeline of biosimilar or generic versions of recombinant therapeutic proteins based on its plant cell-based expression technology, which focuses pharmaceutical markets and that rely upon known biological mechanisms of action. ProCellEx protein expression system consists of a set of technologies and capabilities for the development of recombinant proteins, including advanced genetic engineering technology and plant cell-based protein expression methods. Its ProCellEx protein expression system is built on flexible custom-designed bioreactors made of polyethylene and optimized for the development of complex proteins in plant cell cultures. In June 2010, it had completed the preliminary phase I clinical trial of PRX-105.Taliglucerase AlfaTaliglucerase alfa is a plant cell expressed recombinant glucocerebrosidase enzyme (GCD) for the treatment of Gaucher disease. The Company has commenced pre-clinical studies of an oral form of taliglucerase alfa. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  PLX     avg for
industry  
  avg for
sector  
42 stocks weight:  -1000. 00 M 0. 00   0. 00  
42 stocks rank:  4. 61 K 4. 42 K 4. 42 K
# analyst opinions:  2. 00   2. 00   2. 00  

quick ratio:  1. 71   4. 77   4. 77  
current ratio:  2. 09   4. 86   4. 86  

target price low:  0. 25   14. 94   14. 94  
target price avg:  0. 30   21. 91   21. 91  
target price high:  0. 64   28. 88   28. 88  
1-yr high:  0. 75   22. 10   22. 10  
last close:  0. 39   21. 57   21. 57  
50-day avg:  0. 43   19. 21   19. 21  
200-day avg:  0. 47   15. 43   15. 43  
1-yr low:  0. 29   11. 51   11. 51  
volume:  79. 66 K 7. 22 K 7. 22 K
50-day avg volume:  298. 22 K 11. 60 K 11. 60 K
200-day avg volume:  551. 62 K 9. 48 K 9. 48 K

1-day return:  -2. 69 % 1. 48 % 1. 48 %
this week return:  -3. 25 % 8. 64 % 8. 64 %
12-wk return:  -21. 02 % 43. 48 % 43. 48 %
52-wk return:  -3. 72 % 26. 43 % 26. 43 %

enterprise value (EV):  75. 89 M 625. 52 M 625. 58 M
market cap:  58. 85 M 10020. 31 Q 10020. 30 Q
EBITDA:  -17. 64 M 264. 09   4. 25 K
enterprise multiple (EV/EBITDA):  -4. 30   0. 00   0. 00  
enterprise/revenue (EV/R):  2. 22   0. 00   0. 00  
total revenue:  34. 24 M 621. 35   20. 51 K
total debt:  52. 27 M 687. 38   8. 99 K
net income (common):  -26. 46 M 127. 96   2. 24 K

shares outstanding:  148. 38 M 30. 69 M 30. 69 M
shares:  144. 79 M 24. 61 M 24. 61 M
shares short:  2. 75 M 138. 34 K 138. 35 K
shares short prior month:  2. 78 M 144. 84 K 144. 84 K
short ratio:  13. 65   9. 69   9. 69  
short % of float:  1. 90 % 0. 00 % 0. 00 %
total cash/share:  0. 26   0. 00   0. 00  
total cash:  37. 81 M 350. 59   3. 09 K
free cash flow:  -3. 23 M 185. 71   2. 61 K
operating cash flow:  -7. 74 M 240. 38   3. 12 K

book value:  -0. 36   6. 32   6. 32  
price/book:  -1. 09   3. 41   3. 41  
gross profits:  24. 94 M 34. 62 M 34. 64 M
operating margins:  -56. 39 % -0. 00 % -0. 00 %
EBITDA margins:  -51. 51 % 2157. 19 % 2157. 19 %
profit margins:  -77. 27 % 1950. 54 % 1950. 54 %
gross margins:  72. 83 % 92. 77 % 92. 77 %

1-yr max volatility:  21. 67 % --- ---
1-yr mean volatility:  0. 05 % 0. 20 % 0. 20 %

1-yr EPS:  -0. 18   3. 00   3. 00  
forward EPS:  0. 35   -1. 96   -1. 96  
P/E:  -2. 15   7. 18   7. 18  
forward P/E:  1. 17   -10. 34   -10. 34  
PE/G:  -0. 02   9. 74 B 9. 74 B
growth:  140. 50 % 0. 00 % 0. 00 %
earnings high:  0. 00   -0. 50   -0. 50  
earnings avg:  -0. 02   -0. 50   -0. 50  
earnings low:  -0. 04   -0. 50   -0. 50  
revenue high:  12. 50 M 5. 57 M 5. 58 M
revenue avg:  11. 40 M 5. 57 M 5. 58 M
revenue low:  10. 30 M 5. 57 M 5. 58 M
return on assets:  -18. 10 % 38. 37 % 38. 37 %
revenue growth:  140. 50 % 0. 00 % 0. 00 %
revenue/share:  0. 23   0. 00   0. 00  

beta (1yr vs S&P500):  0. 83   1. 22   1. 22  
sharpe (1yr):  0. 19   0. 84   0. 84  

held % insiders:  6. 23 % 0. 00 % 0. 00 %
held % institutions:  9. 70 % 9. 00 % 9. 00 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-05-24 : PLX
.      0.622 =         0.622 :: INITIAL WEIGHT
.   + 36.375 =        36.997 :: spline projection addition
.    x 1.281 =        47.402 :: industry recommendation factor
.    x 3.142 =       148.917 :: EV/R factor
.    x 0.819 =       121.963 :: return on assets factor
.    x 2.279 =       277.901 :: revenue growth factor
.     x 2.43 =       675.312 :: current ratio factor
.    x 1.479 =       999.018 :: quick ratio factor
.    x 1.036 =      1034.965 :: short ratio factor
.    x 2.176 =      2251.925 :: P/E factor
.    x 2.209 =      4974.411 :: PE/G factor
.    x 1.659 =      8254.825 :: beta factor
.    x 0.704 =      5810.873 :: sharpe factor
.    x 0.909 =       5283.21 :: target low factor
.    x 0.936 =      4944.399 :: target mean factor
.    x 1.034 =       5111.18 :: target high factor
.    x 1.756 =      8975.362 :: industry 2-weeks return factor
.    x 0.986 =      8852.097 :: "drift" penalty 2 days ago
.    x 0.954 =      8444.812 :: "drift" penalty 3 days ago
.    x 0.951 =      8035.031 :: "drift" penalty 5 days ago
.    / 4.428 =       1814.49 :: overall "drift" factor
.    x 0.783 =      1421.351 :: largest single-day jump factor
.     x 0.06 =        84.639 :: low price factor
.    x 1.001 =        84.733 :: factor hist industry gain for week 20
.   cubeRoot =         4.392 :: reduced to standardize
.    - 0.768 =         3.624 :: add/subtract for investor sentiment
. -999999999.999 zero/no returns for 14 days out of the past 42x trading days
.                  -999999999.999 :: FINAL WEIGHT for NYSEAMERICAN:PLX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org